Expert Q&A: Labs Must Take a Greater Role in Guiding Clinicians About Abnormal Data
Lee Fleisher, MD, advocates for clearer interpretation of test results by medical laboratory scientists
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Lee Fleisher, MD, advocates for clearer interpretation of test results by medical laboratory scientists
The agency recently announced subtle but significant changes to its policies governing review of new lab tests for COVID-19.
Two lab staffing experts weigh in on current trends and what labs need to do to attract and retain talent in today’s environment.
A roundup of key mergers, acquisitions, and strategic asset purchases in the healthcare industry in September.
The Hilden, Germany-based company is extending its genetic testing profile beyond oncology to neurology biomarkers.
The agency recently stated that current testing capacity is adequate and established limits on its review of new EUA submissions.
ACLA and public health experts warn that current reimbursement rates will hamper US efforts to contain monkeypox spread.
Congress reportedly set to pass a stripped-down version of the FDA user fees bill without the VALID Act component regulating LDTs.
Due to the common misuse of this modifier, the Centers for Medicare & Medicaid Services recently issued important new guidance on its proper use.
This month’s key lab cases involve false billing of urine drug and PGx tests and two lawsuits that were tossed.
A recent $3.5 million settlement illustrates the kinds of pitfalls that can result in liability for hospital and freestanding sleep labs.